Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > Valeant Pharmaceuticals Expects Sharp Recovery
View:
Post by Valeant on Jan 19, 2016 1:35am

Valeant Pharmaceuticals Expects Sharp Recovery

Although Valeant Pharmaceuticals (VRX) listed on TSX today broke even (+0.02%), markets in the US were closed for Martin Luther King Day.

NYSE re-open tommorow. The following weeks will be positive for VRX. Here is why:

https://twitter.com/Valeant_Defense/status/688409218584465408

Science does not lie.
Comment by puma1 on Jan 25, 2016 7:38am
I have never seen a board with such an obsessed nut case posting. I just started picking up a few VRX and thought I would see what SH has to say. It would be funny if he wasnt such a waste of time. Anyway, a couple of ignores added and the site cleans up. With adjusted numbers of some CDN $18 plus a share, the fundementals will come back into the share price.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities